Potential Cost Savings in Medicare Part D Across Gastroenterology; An Assessment of Alternative Drug Sourcing.

Bouvette Christopher Bouvette MaxYohannan BryceRumman AmirAli Ijlal

Published in: The American journal of gastroenterology (2023)

Disproportionate Part D spending likely reflects less competitive acquisition cost. Provider awareness of medications with advantaged price may promote targeted prescribing with potentially tremendous healthcare savings.

Keyphrases

primary care
healthcare
adverse drug
cancer therapy
drug induced
climate change
social media
health insurance